Showing 1 - 20 results of 7,071 for search '"Antibodies, Bispecific"', query time: 1.36s Refine Results
1
Academic Journal

Authors: Topp M; Universitätsklinikum Würzburg, Würzburg, Germany., Dlugosz-Danecka M; Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland., Skotnicki AB; Department of Haematology, Jagiellonian University, Kraków, Poland., Salogub G; Almazova National Medical Research Center, St Petersburg, Russia., Viardot A; Klinik Für Innere Medizin III, Universitätsklinikum Ulm, Ulm, Germany., Klein AK; Tufts Medical Center, Boston, MA, USA., Hess G; Universitätsmedizin Mainz, Mainz, Germany., Michel CS; Universitätsmedizin Mainz, Mainz, Germany., Grosicki S; Department of Hematology and Cancer Prevention, Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland., Gural A; Hadassah Medical Center, Jerusalem, Israel., Schwarz SE; Affimed GmbH, Heidelberg, Germany., Pietzko K; Affimed GmbH, Heidelberg, Germany., Gärtner U; Affimed GmbH, Heidelberg, Germany. u.gaertner@affimed.com., Strassz A; Affimed GmbH, Heidelberg, Germany., Alland L; Affimed GmbH, Heidelberg, Germany., Mayer J; University Hospital Brno, and Masaryk University, Brno, Czech Republic.

Source: Trials [Trials] 2023 Jan 03; Vol. 24 (1), pp. 4. Date of Electronic Publication: 2023 Jan 03.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

HTML Full Text     PDF Full Text
2
Academic Journal

Authors: Belzer A; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., Nguyen MO; Department of Dermatology, University of California, Irvine School of Medicine, Irvine., Talsania A; Department of Medical Oncology, Yale School of Medicine, New Haven, Connecticut., Haldas J; Department of Medical Oncology, Yale School of Medicine, New Haven, Connecticut., Smith J; Department of Dermatology, University of California, Irvine School of Medicine, Irvine., Leventhal JS; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

Source: JAMA dermatology [JAMA Dermatol] 2023 Jan 01; Vol. 159 (1), pp. 109-111.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

HTML Full Text     PDF Full Text
3
Academic Journal

Authors: Ni B; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China., Hou J; Department of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

Source: Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 343-352.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE

HTML Full Text     PDF Full Text
4
Academic Journal

Authors: Zhou H; Nanfang Hospital, Southern Medical University, Guangzhou, China., Yin Q; Henan Cancer Hospital, Zhengzhou, China., Jin J; The First Affiliated Hospital, College of Medicine, Zhejiang University College of Medicine, Hangzhou, China., Liu T; West China Hospital, Sichuan University, Chengdu, China., Cai Z; The First Affiliated Hospital, College of Medicine, Zhejiang University College of Medicine, Hangzhou, China., Jiang B; Peking University International Hospital, Beijing, China., Li D; Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China., Sun Z; Anhui Provincial Hospital, Hefei, China., Li Y; The First Hospital of China Medical University, Shenyang, China., He Y; Xiangya Hospital Central South University, Changsha, China., Ma L; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China., Gao S; The First Hospital of Jilin University, Jilin, China., Hu J; Fujian Medical University Union Hospital, Fujian, China., He A; The Second Affiliated Hospital of Xian Jiaotong University, Shaanxi, China., Du X; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Liu D; Chinese People Liberation Army General Hospital, Beijing, China., Zhang X; The Second Affiliated Hospital Zhejiang University College of Medicine, Zhejiang, China., Ke X; Peking University Third Hospital, Beijing, China., Zhuang J; Peking Union Medical College Hospital, Beijing, China., Han Y; The First Affiliated Hospital of Soochow University, Jiangsu, China., Wang X; Huashan Hospital Affiliated to Fudan University, Shanghai, China., Chen Y; Global Biostatistical Sciences, Amgen Inc., Thousand Oaks, CA, USA., Gordon P; Global Development, Amgen Inc., Thousand Oaks, CA, USA., Yu D; Amgen China, Shanghai, People's Republic of China., Zugmaier G; Global Development, Amgen Research (Munich) GmbH, Munich, Germany., Wang J; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People's Republic of China.

Source: Hematology (Amsterdam, Netherlands) [Hematology] 2022 Dec; Vol. 27 (1), pp. 917-927.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE

HTML Full Text     PDF Full Text
5
Academic Journal

Authors: Hao S; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China., Xu S; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China., Li L; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China., Li Y; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China., Zhao M; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China., Chen J; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China., Zhu S; Institute of Translational Medicine, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China., Xie Y; Jecho Laboratories, Inc, 7320 Executive Way, 21704, Frederick, MD, USA., Jiang H; Jecho Laboratories, Inc, 7320 Executive Way, 21704, Frederick, MD, USA., Zhu J; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China. jianweiz@sjtu.edu.cn.; Jecho Laboratories, Inc, 7320 Executive Way, 21704, Frederick, MD, USA. jianweiz@sjtu.edu.cn., Wu M; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, 200240, Shanghai, People's Republic of China. wumingyuan@sjtu.edu.cn.

Source: BMC cancer [BMC Cancer] 2022 Oct 25; Vol. 22 (1), pp. 1092. Date of Electronic Publication: 2022 Oct 25.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

HTML Full Text     PDF Full Text
6
Academic Journal

Authors: Yi M; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China.; Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310000, People's Republic of China., Niu M; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China., Wu Y; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China., Ge H; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, People's Republic of China., Jiao D; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China., Zhu S; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China., Zhang J; Wuhan YZY Biopharma Co., Ltd, C2-1, No.666 Gaoxin Road, Biolake, Wuhan, 430075, People's Republic of China., Yan Y; Wuhan YZY Biopharma Co., Ltd, C2-1, No.666 Gaoxin Road, Biolake, Wuhan, 430075, People's Republic of China., Zhou P; Wuhan YZY Biopharma Co., Ltd, C2-1, No.666 Gaoxin Road, Biolake, Wuhan, 430075, People's Republic of China., Chu Q; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. qianchu@tjh.tjmu.edu.cn., Wu K; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. wukm_lab@163.com.; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China. wukm_lab@163.com.

Source: Journal of hematology & oncology [J Hematol Oncol] 2022 Oct 08; Vol. 15 (1), pp. 142. Date of Electronic Publication: 2022 Oct 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

HTML Full Text     PDF Full Text
7
Academic Journal

Authors: Sano Y; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan. sanoyuj@chugai-pharm.co.jp., Azuma Y; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Tsunenari T; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Kayukawa Y; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Shinozuka J; Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan., Fujii E; Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan., Amano J; Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan., Nishito Y; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Maruyama T; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Kinoshita Y; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Sakamoto Y; Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan., Yoshida A; Chugai Research Institute for Medical Science, Inc., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan., Miyazaki Y; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Sato Y; Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan., Teramoto-Seida C; Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka, 412-8513, Japan., Ishiguro T; Translational Research Division, Chugai Pharmaceutical Co., Ltd., 1-1Nihonbashi-Muromachi 2-Chome Chuo-ku, Tokyo, 103-8324, Japan., Tanaka T; Translational Research Division, Chugai Pharmaceutical Co., Ltd., 1-1Nihonbashi-Muromachi 2-Chome Chuo-ku, Tokyo, 103-8324, Japan., Kitazawa T; Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Endo M; Translational Research Division, Chugai Pharmaceutical Co., Ltd., 1-1Nihonbashi-Muromachi 2-Chome Chuo-ku, Tokyo, 103-8324, Japan.

Source: Nature communications [Nat Commun] 2022 Sep 07; Vol. 13 (1), pp. 5265. Date of Electronic Publication: 2022 Sep 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

HTML Full Text     PDF Full Text
8
Academic Journal

Authors: Moshoette T; HIV Pathogenesis Research Unit, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa., Papathanasopoulos MA; HIV Pathogenesis Research Unit, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa., Killick MA; HIV Pathogenesis Research Unit, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa. Mark.Killick@wits.ac.za.

Source: Virology journal [Virol J] 2022 Sep 07; Vol. 19 (1), pp. 143. Date of Electronic Publication: 2022 Sep 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X (Electronic) Linking ISSN: 1743422X NLM ISO Abbreviation: Virol J Subsets: MEDLINE

HTML Full Text     PDF Full Text
9
Academic Journal

Authors: Kadam AH; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Kandasamy K; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Buss T; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Cederstrom B; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Yang C; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Narayanapillai S; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Rodriguez J; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Levin MD; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Koziol J; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Olenyuk B; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Borok Z; Department of Medicine, UCSD School of Medicine, La Jolla, California, United States of America., Chrastina A; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America., Schnitzer JE; Proteogenomics Research Institute for Systems Medicine (PRISM), La Jolla, California, United States of America.; Institute for Engineering in Medicine, UCSD, La Jolla, California, United States of America.

Source: PloS one [PLoS One] 2022 Nov 22; Vol. 17 (11), pp. e0276462. Date of Electronic Publication: 2022 Nov 22 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

HTML Full Text     PDF Full Text
10
Academic Journal

Authors: Chang MR; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Tomasovic L; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Kuzmina NA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, Galveston, TX, 77555, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Ronk AJ; Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, Galveston, TX, 77555, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Byrne PO; Department of Molecular Biosciences, University of Texas, Austin, TX, 78712, USA., Johnson R; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University, School of Medicine, Boston, MA, 02118, USA., Storm N; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University, School of Medicine, Boston, MA, 02118, USA., Olmedillas E; La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Hou YJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Leist SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Tse LV; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Ke H; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Coherd C; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Nguyen K; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Kamkaew M; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Honko A; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University, School of Medicine, Boston, MA, 02118, USA., Zhu Q; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA., Alter G; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, 02139, USA., Saphire EO; La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., McLellan JS; Department of Molecular Biosciences, University of Texas, Austin, TX, 78712, USA., Griffiths A; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University, School of Medicine, Boston, MA, 02118, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Galveston National Laboratory, Galveston, TX, 77555, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA., Marasco WA; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. Wayne_Marasco@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA. Wayne_Marasco@dfci.harvard.edu.

Source: Nature communications [Nat Commun] 2022 Oct 03; Vol. 13 (1), pp. 5814. Date of Electronic Publication: 2022 Oct 03.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

HTML Full Text     PDF Full Text
11
Academic Journal

Authors: Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.; Center for Infectious Disease Research, Science of Life Sciences, Westlake University, Hangzhou, Zhejiang, China., Xie X; Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, Sealy Institute for Vaccine Sciences, Sealy Center for Structural Biology & Molecular Biophysics, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Lin J; NTU Institute of Structural Biology and School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Gao P; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Wu B; NTU Institute of Structural Biology and School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., El Sahili A; NTU Institute of Structural Biology and School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Su H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Liu Y; Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, Sealy Institute for Vaccine Sciences, Sealy Center for Structural Biology & Molecular Biophysics, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Ye X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.; Center for Infectious Disease Research, Science of Life Sciences, Westlake University, Hangzhou, Zhejiang, China., Tan EY; NTU Institute of Structural Biology and School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Li X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Fan X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Goh BC; NTU Institute of Structural Biology and School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.; Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore., Xiong W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Boyd H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Muruato AE; Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, Sealy Institute for Vaccine Sciences, Sealy Center for Structural Biology & Molecular Biophysics, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Deng H; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Xia H; Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, Sealy Institute for Vaccine Sciences, Sealy Center for Structural Biology & Molecular Biophysics, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Zou J; Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, Sealy Institute for Vaccine Sciences, Sealy Center for Structural Biology & Molecular Biophysics, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Kalveram BK; Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, Sealy Institute for Vaccine Sciences, Sealy Center for Structural Biology & Molecular Biophysics, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA., Menachery VD; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA., Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA., Lescar J; NTU Institute of Structural Biology and School of Biological Sciences, Nanyang Technological University, Singapore, Singapore. Julien@ntu.edu.sg., Shi PY; Department of Biochemistry and Molecular Biology, Institute for Human Infection and Immunity, Sealy Institute for Vaccine Sciences, Sealy Center for Structural Biology & Molecular Biophysics, Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA. peshi@UTMB.EDU., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA. Zhiqiang.An@uth.tmc.edu.

Source: Nature communications [Nat Commun] 2022 Sep 22; Vol. 13 (1), pp. 5552. Date of Electronic Publication: 2022 Sep 22.

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

HTML Full Text     PDF Full Text
12
Academic Journal

Authors: Zheng S; Clinical and Quantitative Pharmacology, Adagene, San Diego, California, USA., Prell R; Safety Assessment, Genentech, South San Francisco, California, USA., Sheng J; Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Princeton, New Jersey, USA., Wang YM; Office of Clinical Pharmacology, OTS/CDER/FDA, Silver Spring, Maryland, USA., Hamuro L; Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Princeton, New Jersey, USA.

Source: Clinical and translational science [Clin Transl Sci] 2022 Sep; Vol. 15 (9), pp. 2096-2104. Date of Electronic Publication: 2022 Jun 11.

Publication Type: Journal Article; Review

Journal Info: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

HTML Full Text     PDF Full Text
13
Academic Journal

Authors: Cheal SM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York; cheals@mskcc.org., Chung SK; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York., Vaughn BA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Cheung NV; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York; and., Larson SM; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Sep; Vol. 63 (9), pp. 1302-1315.

Publication Type: Journal Article; Review

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

PDF Full Text
14
Academic Journal

Authors: Glonnegger H; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. hannah.glonnegger@uniklinik-freiburg.de., Andresen F; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kapp F; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Malvestiti S; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Büchsel M; Institute of Clinical Chemistry and Laboratory Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Zieger B; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Source: BMC pediatrics [BMC Pediatr] 2022 Aug 15; Vol. 22 (1), pp. 487. Date of Electronic Publication: 2022 Aug 15.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967804 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2431 (Electronic) Linking ISSN: 14712431 NLM ISO Abbreviation: BMC Pediatr Subsets: MEDLINE

HTML Full Text     PDF Full Text
15

Authors: Allan JN; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York.

Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2022 Aug; Vol. 20 (8), pp. 500-502.

Publication Type: Interview

Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE

PDF Full Text
16
Academic Journal

Authors: Nejadghaderi SA; Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Balibegloo M; Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Saghazadeh A; Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran., Rezaei N; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran.; Department of Immunology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

Source: PloS one [PLoS One] 2022 Jul 18; Vol. 17 (7), pp. e0271506. Date of Electronic Publication: 2022 Jul 18 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

HTML Full Text     PDF Full Text
17
Academic Journal

Authors: Hamedani NS; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany., Oldenburg J; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany., Pötzsch B; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany., Müller J; Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.

Source: PloS one [PLoS One] 2022 Jul 14; Vol. 17 (7), pp. e0271330. Date of Electronic Publication: 2022 Jul 14 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

HTML Full Text     PDF Full Text
18
Academic Journal

Authors: Yamaguchi T; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan., Shinozawa K; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan., Nagatoishi S; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Mitsuhashi A; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan; Research Resident Fellowship, Japan Foundation for AIDS Prevention, Tokyo, Japan., Bingo M; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan., Inaba H; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan., Amano K; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan., Tsumoto K; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan., Kinai E; Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan. Electronic address: ekinai@tokyo-med.ac.jp.

Source: Thrombosis research [Thromb Res] 2023 Feb; Vol. 222, pp. 131-139. Date of Electronic Publication: 2023 Jan 13.

Publication Type: Journal Article

Journal Info: Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2472 (Electronic) Linking ISSN: 00493848 NLM ISO Abbreviation: Thromb Res Subsets: MEDLINE

19
Academic Journal

Authors: Nelson MH; Aptevo Therapeutics Inc., Seattle, Washington., Fritzell S; Alligator Bioscience AB, Lund, Sweden., Miller R; Aptevo Therapeutics Inc., Seattle, Washington., Werchau D; Alligator Bioscience AB, Lund, Sweden., Van Citters D; Aptevo Therapeutics Inc., Seattle, Washington., Nilsson A; Alligator Bioscience AB, Lund, Sweden., Misher L; Aptevo Therapeutics Inc., Seattle, Washington., Ljung L; Alligator Bioscience AB, Lund, Sweden., Bader R; Aptevo Therapeutics Inc., Seattle, Washington., Deronic A; Alligator Bioscience AB, Lund, Sweden., Chunyk AG; Aptevo Therapeutics Inc., Seattle, Washington., Schultz L; Alligator Bioscience AB, Lund, Sweden., Varas LA; Alligator Bioscience AB, Lund, Sweden., Rose N; Saromics Biostructures AB, Lund, Sweden., Håkansson M; Saromics Biostructures AB, Lund, Sweden., Gross J; Aptevo Therapeutics Inc., Seattle, Washington., Furebring C; Alligator Bioscience AB, Lund, Sweden., Pavlik P; Aptevo Therapeutics Inc., Seattle, Washington., Sundstedt A; Alligator Bioscience AB, Lund, Sweden., Veitonmäki N; Alligator Bioscience AB, Lund, Sweden., Ramos HJ; Aptevo Therapeutics Inc., Seattle, Washington., Säll A; Alligator Bioscience AB, Lund, Sweden., Dahlman A; Alligator Bioscience AB, Lund, Sweden., Bienvenue D; Aptevo Therapeutics Inc., Seattle, Washington., von Schantz L; Alligator Bioscience AB, Lund, Sweden., McMahan CJ; Aptevo Therapeutics Inc., Seattle, Washington., Askmyr M; Alligator Bioscience AB, Lund, Sweden., Hernandez-Hoyos G; Aptevo Therapeutics Inc., Seattle, Washington., Ellmark P; Alligator Bioscience AB, Lund, Sweden.; Department of Immunotechnology, Lund University, Lund, Sweden.

Source: Molecular cancer therapeutics [Mol Cancer Ther] 2023 Jan 03; Vol. 22 (1), pp. 89-101.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

20
Editorial & Opinion

Authors: Marro M; Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France., Petit AF; Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France., Falaise C; Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France., Roche M; Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France., Gensollen S; Department of Pharmacy, APHM, La Conception Hospital, Marseille, France., Hezard N; Laboratory of Hematology, APHM, La Timone Hospital, Marseille, France., Boucekine M; CERESS, Aix Marseille Univ, Marseille, France., Auquier P; CERESS, Aix Marseille Univ, Marseille, France., Chambost H; Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France.; INSERM, INRAe, C2VN, Aix Marseille Univ, Marseille, France., Saultier P; Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France.; INSERM, INRAe, C2VN, Aix Marseille Univ, Marseille, France.

Source: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2023 Jan; Vol. 29 (1), pp. 397-400. Date of Electronic Publication: 2022 Dec 16.

Publication Type: Letter

Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2516 (Electronic) Linking ISSN: 13518216 NLM ISO Abbreviation: Haemophilia Subsets: MEDLINE